Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
AU-15506
i
Other names:
AU-15506
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Dr. Reddy’s
Drug class:
CDK12/13 inhibitor
Related drugs:
‹
AU-16770 (1)
AU-16770 (1)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
EGFR mutation
Lung Adenocarcinoma
EGFR mutation
Lung Adenocarcinoma
osimertinib + AU-15506
Sensitive: D – Preclinical
osimertinib + AU-15506
Sensitive
:
D
osimertinib + AU-15506
Sensitive: D – Preclinical
osimertinib + AU-15506
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.